Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: Effect on bleeding symptoms and socioeconomic factors
- 1 May 1993
- journal article
- Published by Springer Nature in Annals of Hematology
- Vol. 66 (5), 257-260
- https://doi.org/10.1007/bf01738476
Abstract
Desmopressin (1-desamino-8-D-arginine vasopressin), an established hemostatic agent for the treatment of bleeding in mild hemophilia A, von Willebrand's disease, or platelet disorders, has mostly been given parenterally as intravenous or subcutaneous injections. Intranasal administration by spray has been shown to yield significant and highly reproducible increases in the plasma concentrations of factor VIII and von Willebrand factor and platelet adhesiveness, and to be suitable for self-administration at home, as it is easy to handle and does not involve the use of needles. This paper presents data from a questionnaire answered by 78 patients with mild hemophilia A, von Willebrand's disease, or platelet disorders, who had used the spray at home to treat bleeding symptoms. The patients experienced decreased blood loss and shortened duration of epistaxis, menorrhagia, tissue bleeding, and bleeding in connection with minor surgery or tooth extraction. The use of factor VIII concentrates was diminished, as were the number of visits to outpatient care and absence from school or work.Keywords
This publication has 16 references indexed in Scilit:
- DDAVP‐induced enhancement of platelet retention: Its dependence on platelet‐von Willebrand Factor and the platelet receptor GP IIb/IIIaEuropean Journal of Haematology, 1992
- Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type IBlut: Zeitschrift für die Gesamte Blutforschung, 1990
- Subcutaneous Injection of Desmopressin (DDAVP): Evaluation of a New, More Concentrated PreparationPathophysiology of Haemostasis and Thrombosis, 1989
- Clinical efficacy of desmopressin acetate for hemostatic control in patients with primary platelet disorders undergoing surgeryAmerican Journal of Hematology, 1987
- Intranasal Administration of Peptides: Nasal Deposition, Biological Response, and Absorption of DesmopressinJournal of Pharmaceutical Sciences, 1986
- SHORTENING OF BLEEDING TIME BY 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN VARIOUS BLEEDING DISORDERSThe Lancet, 1984
- DDAVP: A useful alternative to blood components in moderate hemophilia A and von Willebrand diseaseThe Journal of Pediatrics, 1983
- Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's DiseaseBritish Journal of Haematology, 1981
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975